hothouse therapeutics limited
hothouse therapeutics limited Company Information
Company Number
12687410
Next Accounts
Mar 2026
Shareholders
anne osbourn
james reed
View AllGroup Structure
View All
Industry
Research and experimental development on biotechnology
Registered Address
centrum norwich research park, colney lane, norwich, norfolk, NR4 7GJ
Website
-hothouse therapeutics limited Estimated Valuation
Pomanda estimates the enterprise value of HOTHOUSE THERAPEUTICS LIMITED at £30.6k based on a Turnover of £30.4k and 1.01x industry multiple (adjusted for size and gross margin).
hothouse therapeutics limited Estimated Valuation
Pomanda estimates the enterprise value of HOTHOUSE THERAPEUTICS LIMITED at £0 based on an EBITDA of £-505 and a 3.97x industry multiple (adjusted for size and gross margin).
hothouse therapeutics limited Estimated Valuation
Pomanda estimates the enterprise value of HOTHOUSE THERAPEUTICS LIMITED at £0 based on Net Assets of £-375 and 1.79x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Hothouse Therapeutics Limited Overview
Hothouse Therapeutics Limited is a live company located in norwich, NR4 7GJ with a Companies House number of 12687410. It operates in the research and experimental development on biotechnology sector, SIC Code 72110. Founded in June 2020, it's largest shareholder is anne osbourn with a 26.2% stake. Hothouse Therapeutics Limited is a young, micro sized company, Pomanda has estimated its turnover at £30.4k with unknown growth in recent years.
Upgrade for unlimited company reports & a free credit check
Hothouse Therapeutics Limited Health Check
Pomanda's financial health check has awarded Hothouse Therapeutics Limited a 2 rating. We use a traffic light system to show it exceeds the industry average on 2 measures and has 5 areas for improvement. Company Health Check FAQs
2 Strong
1 Regular
5 Weak
Size
annual sales of £30.4k, make it smaller than the average company (£3.9m)
- Hothouse Therapeutics Limited
£3.9m - Industry AVG
Growth
There is insufficient data available for this Key Performance Indicator!
- Hothouse Therapeutics Limited
- - Industry AVG
Production
with a gross margin of 28.5%, this company has a higher cost of product (55.3%)
- Hothouse Therapeutics Limited
55.3% - Industry AVG
Profitability
an operating margin of -1.7% make it more profitable than the average company (-10.2%)
- Hothouse Therapeutics Limited
-10.2% - Industry AVG
Employees
with 1 employees, this is below the industry average (48)
1 - Hothouse Therapeutics Limited
48 - Industry AVG
Pay Structure
on an average salary of £81.8k, the company has an equivalent pay structure (£81.8k)
- Hothouse Therapeutics Limited
£81.8k - Industry AVG
Efficiency
resulting in sales per employee of £30.4k, this is less efficient (£130.8k)
- Hothouse Therapeutics Limited
£130.8k - Industry AVG
Debtor Days
it gets paid by customers after 6 days, this is earlier than average (54 days)
- Hothouse Therapeutics Limited
54 days - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- Hothouse Therapeutics Limited
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Hothouse Therapeutics Limited
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Hothouse Therapeutics Limited
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 171.4%, this is a higher level of debt than the average (50.9%)
171.4% - Hothouse Therapeutics Limited
50.9% - Industry AVG
HOTHOUSE THERAPEUTICS LIMITED financials
Hothouse Therapeutics Limited's latest turnover from June 2024 is estimated at £30.4 thousand and the company has net assets of -£375. According to their latest financial statements, Hothouse Therapeutics Limited has 1 employee and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | |
|---|---|---|---|---|
| Turnover | ||||
| Other Income Or Grants | ||||
| Cost Of Sales | ||||
| Gross Profit | ||||
| Admin Expenses | ||||
| Operating Profit | ||||
| Interest Payable | ||||
| Interest Receivable | ||||
| Pre-Tax Profit | ||||
| Tax | ||||
| Profit After Tax | ||||
| Dividends Paid | ||||
| Retained Profit | ||||
| Employee Costs | ||||
| Number Of Employees | 1 | 1 | ||
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | |
|---|---|---|---|---|
| Tangible Assets | ||||
| Intangible Assets | ||||
| Investments & Other | 130 | 100 | 100 | |
| Debtors (Due After 1 year) | ||||
| Total Fixed Assets | 130 | 100 | 100 | |
| Stock & work in progress | ||||
| Trade Debtors | 525 | |||
| Group Debtors | ||||
| Misc Debtors | ||||
| Cash | ||||
| misc current assets | ||||
| total current assets | 525 | |||
| total assets | 525 | 130 | 100 | 100 |
| Bank overdraft | ||||
| Bank loan | ||||
| Trade Creditors | ||||
| Group/Directors Accounts | ||||
| other short term finances | ||||
| hp & lease commitments | ||||
| other current liabilities | ||||
| total current liabilities | ||||
| loans | ||||
| hp & lease commitments | ||||
| Accruals and Deferred Income | 900 | |||
| other liabilities | ||||
| provisions | ||||
| total long term liabilities | 900 | |||
| total liabilities | 900 | |||
| net assets | -375 | 130 | 100 | 100 |
| total shareholders funds | -375 | 130 | 100 | 100 |
| Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | |
|---|---|---|---|---|
| Operating Activities | ||||
| Operating Profit | ||||
| Depreciation | ||||
| Amortisation | ||||
| Tax | ||||
| Stock | ||||
| Debtors | 525 | |||
| Creditors | ||||
| Accruals and Deferred Income | 900 | |||
| Deferred Taxes & Provisions | ||||
| Cash flow from operations | ||||
| Investing Activities | ||||
| capital expenditure | ||||
| Change in Investments | -130 | 30 | 100 | |
| cash flow from investments | ||||
| Financing Activities | ||||
| Bank loans | ||||
| Group/Directors Accounts | ||||
| Other Short Term Loans | ||||
| Long term loans | ||||
| Hire Purchase and Lease Commitments | ||||
| other long term liabilities | ||||
| share issue | ||||
| interest | ||||
| cash flow from financing | ||||
| cash and cash equivalents | ||||
| cash | ||||
| overdraft | ||||
| change in cash |
hothouse therapeutics limited Credit Report and Business Information
Hothouse Therapeutics Limited Competitor Analysis
Perform a competitor analysis for hothouse therapeutics limited by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other micro companies, companies in NR4 area or any other competitors across 12 key performance metrics.
hothouse therapeutics limited Ownership
HOTHOUSE THERAPEUTICS LIMITED group structure
Hothouse Therapeutics Limited has no subsidiary companies.
Ultimate parent company
HOTHOUSE THERAPEUTICS LIMITED
12687410
hothouse therapeutics limited directors
Hothouse Therapeutics Limited currently has 4 directors. The longest serving directors include Mr Antoine Pechin (Jul 2024) and Professor Anne Osbourn (Jul 2024).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Antoine Pechin | England | 41 years | Jul 2024 | - | Director |
| Professor Anne Osbourn | United Kingdom | 63 years | Jul 2024 | - | Director |
| Dr David Sheppard | United Kingdom | 51 years | Jul 2024 | - | Director |
| Dr Ivan Griffin | United Kingdom | 48 years | Feb 2025 | - | Director |
P&L
June 2024turnover
30.4k
-47%
operating profit
-505
0%
gross margin
28.5%
+7.04%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
June 2024net assets
-375
-3.88%
total assets
525
+3.04%
cash
0
0%
net assets
Total assets minus all liabilities
Similar Companies
hothouse therapeutics limited company details
company number
12687410
Type
Private limited with Share Capital
industry
72110 - Research and experimental development on biotechnology
incorporation date
June 2020
age
5
incorporated
UK
ultimate parent company
accounts
Micro-Entity Accounts
last accounts submitted
June 2024
previous names
hothouse bioengineering limited (March 2023)
accountant
-
auditor
-
address
centrum norwich research park, colney lane, norwich, norfolk, NR4 7GJ
Bank
-
Legal Advisor
-
hothouse therapeutics limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to hothouse therapeutics limited.
hothouse therapeutics limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for HOTHOUSE THERAPEUTICS LIMITED. This can take several minutes, an email will notify you when this has completed.
hothouse therapeutics limited Companies House Filings - See Documents
| date | description | view/download |
|---|
